Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
Netherlands

Gilde Healthcare

Investment focus

Sectors

Biotech
Edtech
Healthtech

Investment stages

Series A
Series B
Growth

Geographic focus

Europe
Netherlands

Investment thesis

Utrecht-based healthcare specialist with €3B AUM across venture & growth, lower mid-market PE, and climate solutions funds. Backs innovative European and US healthcare companies from biotech to digital health. Focus on Netherlands, Belgium, and Germany.

Typical check size

€10M – €70M

Fund size: €740M (Venture & Growth VI, 2024)

Browse similar check sizes →

Portfolio highlights

Noema Pharma - rare neurological diseases biotech
ProVerum - structural heart disease medtech
Tagworks - bioconjugation chemistry platform

Contact

gildehealthcare.com
Netherlands

Research with AI

Learn more about Gilde Healthcare using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Gilde Healthcare and similar investors look for:

Biotech pitch guideEdtech pitch guideHealthtech pitch guide

More investors in Netherlands

4impactEIT Climate-KICEIT InnoEnergyEndeit CapitalView all in Netherlands

Related resources

Series A fundraising guideSeries A pitch deck guideSeries B fundraising guideGrowth fundraising guideGlossary: Term sheetGlossary: Cap table
Fundraising in Netherlands

Tips, programs, and cultural notes

More Biotech investors

AbingworthACF InvestorsAhren Innovation CapitalAlmi Invest GreenTechView all Biotech investors